应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
AURA Aura Biosciences, Inc.
盘前交易 11-18 05:38:40 EST
7.15
-0.07
-0.97%
盘前
7.44
+0.29
+4.06%
05:06 EST
最高
7.31
最低
7.00
成交量
62.76万
今开
7.20
昨收
7.22
日振幅
4.22%
总市值
7.43亿
流通市值
5.88亿
总股本
1.04亿
成交额
447.96万
换手率
0.76%
流通股本
8,222万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
一汽-大众ID. AURA T6纯电SUV开启全国交付,12.99万元起
IT之家 · 10-02
一汽-大众ID. AURA T6纯电SUV开启全国交付,12.99万元起
一汽-大众ID. AURA T6接入豆包大模型
智通财经 · 08-14
一汽-大众ID. AURA T6接入豆包大模型
Aura Biosciences——与Jefferies签署销售协议,或可出售至多2亿美元普通股(SEC文件披露)
美股速递 · 08-12
Aura Biosciences——与Jefferies签署销售协议,或可出售至多2亿美元普通股(SEC文件披露)
组织重组与资本配置助力Aura Biosciences将现金流跑道延长至2029年上半年
美股速递 · 08-11
组织重组与资本配置助力Aura Biosciences将现金流跑道延长至2029年上半年
Aura Biosciences III期COMPASS试验完成108名患者入组,顶线数据预计2027年下半年读出
美股速递 · 08-11
Aura Biosciences III期COMPASS试验完成108名患者入组,顶线数据预计2027年下半年读出
一汽-大众ID. AURA T6开启盲订
智通财经 · 07-30
一汽-大众ID. AURA T6开启盲订
XREAL发布Android XR眼镜AURA:重不到95克集成Gemini AI,今秋上市
凤凰网科技 · 06-17
XREAL发布Android XR眼镜AURA:重不到95克集成Gemini AI,今秋上市
Aura Biosciences宣布Bel-SAR治疗早期脉络膜黑色素瘤的3期Compass试验完成患者入组
美股速递 · 06-01
Aura Biosciences宣布Bel-SAR治疗早期脉络膜黑色素瘤的3期Compass试验完成患者入组
Aura Biosciences, Inc.盘中异动 早盘股价大涨5.15%
市场透视 · 2025-02-26
Aura Biosciences, Inc.盘中异动 早盘股价大涨5.15%
Aura Biosciences, Inc.盘中异动 急速下跌5.19%报7.68美元
市场透视 · 2025-01-24
Aura Biosciences, Inc.盘中异动 急速下跌5.19%报7.68美元
Aura Biosciences, Inc.盘中异动 急速上涨5.29%报8.86美元
市场透视 · 2024-12-17
Aura Biosciences, Inc.盘中异动 急速上涨5.29%报8.86美元
Aura Biosciences, Inc.盘中异动 急速上涨5.68%报8.75美元
市场透视 · 2024-12-06
Aura Biosciences, Inc.盘中异动 急速上涨5.68%报8.75美元
Aura Biosciences, Inc.盘中异动 早盘大幅下挫5.09%
市场透视 · 2024-12-03
Aura Biosciences, Inc.盘中异动 早盘大幅下挫5.09%
Aura Biosciences, Inc.盘中异动 下午盘股价大跌5.22%报9.45美元
市场透视 · 2024-11-16
Aura Biosciences, Inc.盘中异动 下午盘股价大跌5.22%报9.45美元
Aura Biosciences, Inc.2024财年第三财季实现净利润-21.04百万美元,同比减少13.67%
市场透视 · 2024-11-16
Aura Biosciences, Inc.2024财年第三财季实现净利润-21.04百万美元,同比减少13.67%
Aura Biosciences, Inc.盘中异动 股价大跌5.15%报11.05美元
市场透视 · 2024-10-22
Aura Biosciences, Inc.盘中异动 股价大跌5.15%报11.05美元
Aura Biosciences, Inc.股价拉升12.62% 市值涨7254.56万美元
市场透视 · 2024-10-18
Aura Biosciences, Inc.股价拉升12.62% 市值涨7254.56万美元
Aura Biosciences, Inc.盘中异动 股价大涨5.28%报10.38美元
市场透视 · 2024-10-17
Aura Biosciences, Inc.盘中异动 股价大涨5.28%报10.38美元
Aura Biosciences, Inc.盘中异动 大幅拉升5.11%报9.47美元
市场透视 · 2024-09-27
Aura Biosciences, Inc.盘中异动 大幅拉升5.11%报9.47美元
公司概况
公司名称:
Aura Biosciences, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aura Biosciences, Inc.于2009年1月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司,开发治疗实体瘤的精确疗法,旨在保护器官功能。该公司的主要候选产品bel-sar正在进行后期临床开发,用于治疗早期脉络膜黑色素瘤患者,也正在进行其他眼部肿瘤适应症和膀胱癌症的临床开发。
发行价格:
--
{"stockData":{"symbol":"AURA","market":"US","secType":"STK","nameCN":"Aura Biosciences, Inc.","latestPrice":7.15,"timestamp":1794949200000,"preClose":7.22,"halted":0,"volume":627640,"hourTrading":{"tag":"盘前","latestPrice":7.44,"preClose":7.15,"latestTime":"05:06 EST","volume":11,"amount":80.7899994,"timestamp":1794996416252,"change":0.29,"changeRate":0.040559,"amplitude":0.096503},"delay":0,"changeRate":-0.009695290858725678,"floatShares":82218799,"shares":103950771,"eps":-1.606598,"marketStatus":"盘前交易","change":-0.07,"latestTime":"11-18 05:38:40 EST","open":7.2,"high":7.305,"low":7,"amount":4479562.0812800005,"amplitude":0.042244,"askPrice":8.68,"askSize":100,"bidPrice":4.67,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-1.606598,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1795012200000},"marketStatusCode":1,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":7.15,"preHourTrading":{"tag":"盘前","latestPrice":7.44,"preClose":7.15,"latestTime":"05:06 EST","volume":11,"amount":80.7899994,"timestamp":1794996416252,"change":0.29,"changeRate":0.040559,"amplitude":0.096503},"postHourTrading":{"tag":"盘后","latestPrice":7.15,"preClose":7.15,"latestTime":"19:56 EST","volume":6233,"amount":44569.21,"timestamp":1794963412110,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.8005915009165393,"impliedVol":0.6463,"impliedVolPercentile":0.244},"requestUrl":"/m/hq/s/AURA/wiki","defaultTab":"wiki","newsList":[{"id":"2672794245","title":"一汽-大众ID. AURA T6纯电SUV开启全国交付,12.99万元起","url":"https://stock-news.laohu8.com/highlight/detail?id=2672794245","media":"IT之家","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2672794245?lang=zh_cn&edition=full","pubTime":"2026-10-02 11:18","pubTimestamp":1790911090,"startTime":"0","endTime":"0","summary":"IT之家 10 月 2 日消息,一汽-大众今日宣布,ID. AURA T6 今天正式启动全国交付。据IT之家此前报道,一汽-大众 ID. AURA T6 于 9 月 20 日上市,包含四款车型,售价区间 12.99 万 - 16.69 万元:540 Pro:12.99 万元660 Pro:13.99 万元660 Max 激光雷达版:14.99 万元660 Ultra 激光雷达版:16.69 万元新车长宽高分别为 4811/1879/1648mm,轴距 2836mm;配备 15.6 英寸 2.5K 中控屏、25.8 英寸 AR-HUD 及 10.25 英寸全液晶仪表。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8wtJd969xnT","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4139","AURA","LUMA","CABZ","FOTO","IDRV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659119758","title":"一汽-大众ID. AURA T6接入豆包大模型","url":"https://stock-news.laohu8.com/highlight/detail?id=2659119758","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659119758?lang=zh_cn&edition=full","pubTime":"2026-08-14 15:53","pubTimestamp":1786693981,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["EPAI","AURA","GPTZ","LRNZ","WISE","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165877982","title":"Aura Biosciences——与Jefferies签署销售协议,或可出售至多2亿美元普通股(SEC文件披露)","url":"https://stock-news.laohu8.com/highlight/detail?id=1165877982","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1165877982?lang=zh_cn&edition=full","pubTime":"2026-08-12 04:19","pubTimestamp":1786479572,"startTime":"0","endTime":"0","summary":"Aura Biosciences, Inc. 近日披露,根据其与投行Jefferies签署的一份销售协议,公司可能出售至多2亿美元的普通股。这一信息源自美国证券交易委员会(SEC)的相关申报文件。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137039353","title":"组织重组与资本配置助力Aura Biosciences将现金流跑道延长至2029年上半年","url":"https://stock-news.laohu8.com/highlight/detail?id=1137039353","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137039353?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:06","pubTimestamp":1786446396,"startTime":"0","endTime":"0","summary":"Aura Biosciences(Aura Biosciences, Inc.)通过实施组织重组与资本配置策略,显著延长了其现金储备的可持续性,现预期可支撑公司运营至2029年上半年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190931214","title":"Aura Biosciences III期COMPASS试验完成108名患者入组,顶线数据预计2027年下半年读出","url":"https://stock-news.laohu8.com/highlight/detail?id=1190931214","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1190931214?lang=zh_cn&edition=full","pubTime":"2026-08-11 19:06","pubTimestamp":1786446369,"startTime":"0","endTime":"0","summary":"Aura Biosciences公司宣布,其关键的III期COMPASS临床试验已经完成全部患者入组,共计108名受试者。这一里程碑标志着该研究进入关键数据收集阶段。根据公司预期,顶线结果将在2027年下半年对外公布。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655490806","title":"一汽-大众ID. AURA T6开启盲订","url":"https://stock-news.laohu8.com/highlight/detail?id=2655490806","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655490806?lang=zh_cn&edition=full","pubTime":"2026-07-30 22:51","pubTimestamp":1785423115,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4139","AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644971777","title":"XREAL发布Android XR眼镜AURA:重不到95克集成Gemini AI,今秋上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2644971777","media":"凤凰网科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2644971777?lang=zh_cn&edition=full","pubTime":"2026-06-17 11:21","pubTimestamp":1781666478,"startTime":"0","endTime":"0","summary":"软件层面,XREAL AURA深度整合Google Android XR生态及Gemini AI能力。XREAL透露,目前已有数百套开发者套件通过Google此前发布的Android XR Catalyst Developer Program发放至全球开发者手中,以推动娱乐、办公、医疗、体育等领域的XR应用开发。XREAL AURA已在官网开放预订,美国、英国和日本用户可支付99美元参与预订。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8u1j0XEFImp","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"ifeng_tech","symbols":["CHAT","IPOS","AGIX","BK4139","ARTY","AIPO","AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137059152","title":"Aura Biosciences宣布Bel-SAR治疗早期脉络膜黑色素瘤的3期Compass试验完成患者入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1137059152","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1137059152?lang=zh_cn&edition=full","pubTime":"2026-06-01 20:00","pubTimestamp":1780315253,"startTime":"0","endTime":"0","summary":"Aura Biosciences, Inc. 近日宣布,其针对早期脉络膜黑色素瘤的在研疗法Bel-SAR,其关键性3期临床试验“Compass”已完成全部患者入组工作。这一里程碑标志着该创新疗法在临床开发道路上迈出了至关重要的一步,为后续的数据收集与分析奠定了坚实基础。脉络膜黑色素瘤是一种罕见但严重的眼内恶性肿瘤,Bel-SAR作为一种新型靶向疗法,旨在为患者提供一种潜在的有效治疗选择。此次试验的顺利推进,有望为满足这一未竟的医疗需求带来新的希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514859216","title":"Aura Biosciences, Inc.盘中异动 早盘股价大涨5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514859216","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514859216?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:40","pubTimestamp":1740580839,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时40分,Aura Biosciences, Inc.股票出现异动,股价大幅拉升5.15%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.56%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224039abddef59&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226224039abddef59&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505861359","title":"Aura Biosciences, Inc.盘中异动 急速下跌5.19%报7.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505861359","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2505861359?lang=zh_cn&edition=full","pubTime":"2025-01-24 23:00","pubTimestamp":1737730846,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日23时00分,Aura Biosciences, Inc.股票出现异动,股价急速跳水5.19%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230047960f9354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124230047960f9354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2492161244","title":"Aura Biosciences, Inc.盘中异动 急速上涨5.29%报8.86美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492161244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2492161244?lang=zh_cn&edition=full","pubTime":"2024-12-17 01:18","pubTimestamp":1734369487,"startTime":"0","endTime":"0","summary":"北京时间2024年12月17日01时18分,Aura Biosciences, Inc.股票出现异动,股价急速上涨5.29%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为1.02%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011807a1f38d3f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217011807a1f38d3f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2489324992","title":"Aura Biosciences, Inc.盘中异动 急速上涨5.68%报8.75美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489324992","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489324992?lang=zh_cn&edition=full","pubTime":"2024-12-06 23:37","pubTimestamp":1733499471,"startTime":"0","endTime":"0","summary":"北京时间2024年12月06日23时37分,Aura Biosciences, Inc.股票出现波动,股价大幅拉升5.68%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体涨幅为0.69%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233751a1d9915b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241206233751a1d9915b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2488940394","title":"Aura Biosciences, Inc.盘中异动 早盘大幅下挫5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2488940394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2488940394?lang=zh_cn&edition=full","pubTime":"2024-12-03 23:53","pubTimestamp":1733241212,"startTime":"0","endTime":"0","summary":"北京时间2024年12月03日23时53分,Aura Biosciences, Inc.股票出现波动,股价快速下跌5.09%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.49%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203235332abf32267&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241203235332abf32267&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483207581","title":"Aura Biosciences, Inc.盘中异动 下午盘股价大跌5.22%报9.45美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483207581","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483207581?lang=zh_cn&edition=full","pubTime":"2024-11-16 03:34","pubTimestamp":1731699248,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日03时34分,Aura Biosciences, Inc.股票出现波动,股价急速下挫5.22%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为3.85%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033408a23be6fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116033408a23be6fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2483306195","title":"Aura Biosciences, Inc.2024财年第三财季实现净利润-21.04百万美元,同比减少13.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483306195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2483306195?lang=zh_cn&edition=full","pubTime":"2024-11-16 00:00","pubTimestamp":1731686436,"startTime":"0","endTime":"0","summary":"11月16日,Aura Biosciences, Inc.公布财报,公告显示公司2024财年第三财季净利润为-21.04百万美元,同比减少13.67%;其中营业收入为0.00美元,每股基本收益为-0.42美元。从资产负债表来看,Aura Biosciences, Inc.总负债30.67百万美元,其中短期债务3.13百万美元,资产负债比为0.07,流动比率为0.13。机构评级:截至2024年11月16日,当前有7家机构对Aura Biosciences, Inc.目标价做出预测,其中目标均价为22.43美元,其中最低目标价为20.00美元,最高目标价为24.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000322abc5160d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116000322abc5160d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2477352476","title":"Aura Biosciences, Inc.盘中异动 股价大跌5.15%报11.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477352476","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2477352476?lang=zh_cn&edition=full","pubTime":"2024-10-22 23:47","pubTimestamp":1729612037,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日23时47分,Aura Biosciences, Inc.股票出现波动,股价急速下跌5.15%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.38%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223471898e3dceb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024102223471898e3dceb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476370572","title":"Aura Biosciences, Inc.股价拉升12.62% 市值涨7254.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476370572","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476370572?lang=zh_cn&edition=full","pubTime":"2024-10-18 21:31","pubTimestamp":1729258279,"startTime":"0","endTime":"0","summary":"北京时间2024年10月18日21时31分,Aura Biosciences, Inc.股票出现异动,股价快速上涨12.62%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.13%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182131199f4d8920&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410182131199f4d8920&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["AURA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2476943492","title":"Aura Biosciences, Inc.盘中异动 股价大涨5.28%报10.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2476943492","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2476943492?lang=zh_cn&edition=full","pubTime":"2024-10-17 00:04","pubTimestamp":1729094644,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日00时04分,Aura Biosciences, Inc.股票出现异动,股价急速上涨5.28%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.42%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000404ab6a9393&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017000404ab6a9393&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2470103839","title":"Aura Biosciences, Inc.盘中异动 大幅拉升5.11%报9.47美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470103839","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2470103839?lang=zh_cn&edition=full","pubTime":"2024-09-27 23:18","pubTimestamp":1727450280,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日23时18分,Aura Biosciences, Inc.股票出现异动,股价快速上涨5.11%。Aura Biosciences, Inc.股票所在的生物技术行业中,整体跌幅为0.70%。Aura Biosciences, Inc.公司简介:Aura Biosciences Inc 是一家临床阶段的生物技术公司,正在开发精准免疫疗法,用于治疗一系列固体肿瘤,旨在保护受癌症影响的器官功能。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231801ab668705&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927231801ab668705&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","AURA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aurabiosciences.com","stockEarnings":[{"period":"1week","weight":-0.0654},{"period":"1month","weight":0.1721},{"period":"3month","weight":-0.0822},{"period":"6month","weight":-0.0654},{"period":"1year","weight":0.3},{"period":"ytd","weight":0.3119}],"compareEarnings":[{"period":"1week","weight":-0.0233},{"period":"1month","weight":-0.0404},{"period":"3month","weight":-0.0476},{"period":"6month","weight":-0.0138},{"period":"1year","weight":0.1003},{"period":"ytd","weight":0.0741}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aura Biosciences, Inc.于2009年1月根据特拉华州法律注册成立。该公司是一家临床阶段的生物技术公司,开发治疗实体瘤的精确疗法,旨在保护器官功能。该公司的主要候选产品bel-sar正在进行后期临床开发,用于治疗早期脉络膜黑色素瘤患者,也正在进行其他眼部肿瘤适应症和膀胱癌症的临床开发。","yearOnYearQuotes":[{"month":1,"riseRate":0.4,"avgChangeRate":-0.016438},{"month":2,"riseRate":0.4,"avgChangeRate":0.024865},{"month":3,"riseRate":0.4,"avgChangeRate":-0.011666},{"month":4,"riseRate":0.2,"avgChangeRate":-0.052717},{"month":5,"riseRate":0.8,"avgChangeRate":0.068049},{"month":6,"riseRate":0.6,"avgChangeRate":-0.010121},{"month":7,"riseRate":0.6,"avgChangeRate":0.081681},{"month":8,"riseRate":0.2,"avgChangeRate":-0.095877},{"month":9,"riseRate":0.4,"avgChangeRate":0.040615},{"month":10,"riseRate":0.2,"avgChangeRate":-0.053039},{"month":11,"riseRate":0.666667,"avgChangeRate":0.074449},{"month":12,"riseRate":0.2,"avgChangeRate":-0.095533}],"exchange":"NASDAQ","name":"Aura Biosciences, Inc.","nameEN":"Aura Biosciences, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.54.0","shortVersion":"4.54.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aura Biosciences, Inc.(AURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aura Biosciences, Inc.(AURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aura Biosciences, Inc.,AURA,Aura Biosciences, Inc.股票,Aura Biosciences, Inc.股票老虎,Aura Biosciences, Inc.股票老虎国际,Aura Biosciences, Inc.行情,Aura Biosciences, Inc.股票行情,Aura Biosciences, Inc.股价,Aura Biosciences, Inc.股市,Aura Biosciences, Inc.股票价格,Aura Biosciences, Inc.股票交易,Aura Biosciences, Inc.股票购买,Aura Biosciences, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aura Biosciences, Inc.(AURA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aura Biosciences, Inc.(AURA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}